These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1912329)

  • 41. Binding studies and photoaffinity labeling identify two classes of phencyclidine receptors in rat brain.
    Haring R; Kloog Y; Kalir A; Sokolovsky M
    Biochemistry; 1987 Sep; 26(18):5854-61. PubMed ID: 2823887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A specific acylating agent for the [3H]phencyclidine receptors in rat brain.
    Rafferty MF; Mattson M; Jacobson AE; Rice KC
    FEBS Lett; 1985 Feb; 181(2):318-22. PubMed ID: 2982662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GC/MS analysis of phencyclidine acid metabolite in human urine.
    elSohly MA; Little TL; Mitchell JM; Paul BD; Mell LD; Irving J
    J Anal Toxicol; 1988; 12(4):180-2. PubMed ID: 3184886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine.
    Peters FT; Dragan CA; Schwaninger AE; Sauer C; Zapp J; Bureik M; Maurer HH
    Forensic Sci Int; 2009 Jan; 184(1-3):69-73. PubMed ID: 19135815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phencyclidine N-oxide. Synthesis, decomposition and in vitro metabolism studies.
    Hallström G; Nguyen CH; Cho AK
    Acta Pharm Suec; 1983; 20(3):181-92. PubMed ID: 6637516
    [No Abstract]   [Full Text] [Related]  

  • 46. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Castagnoli N; Chiba K; Trevor AJ
    Life Sci; 1985 Jan; 36(3):225-30. PubMed ID: 3871243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships of phencyclidine derivatives in rat cerebellum.
    Pang K; Johnson SW; Maayani S; Freedman R
    Pharmacol Biochem Behav; 1986 Jan; 24(1):127-34. PubMed ID: 3945656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats.
    Kusljic S; Brosda J; Norman TR; van den Buuse M
    Brain Res; 2005 Jul; 1049(2):217-26. PubMed ID: 15953591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of chemical P450 model systems to studies on drug metabolism. I. Phencyclidine: a multi-functional model substrate.
    Masumoto H; Takeuchi K; Ohta S; Hirobe M
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1788-94. PubMed ID: 2805159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doubtful role for phencyclidine metabolites in PCP enhancement of QNB binding.
    Boggan WO; Middaugh LD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):671-6. PubMed ID: 3602029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophilic affinity ligands for the phencyclidine (PCP) receptor.
    Lessor RA; Mattson MV; Rice KC; Jacobson AE
    NIDA Res Monogr; 1986; 67():138-44. PubMed ID: 3018571
    [No Abstract]   [Full Text] [Related]  

  • 53. Stereospecific binding of 3H-phencyclidine in brain membranes.
    Hampton RY; Medzihradsky F; Woods JH; Dahlstrom PJ
    Life Sci; 1982 Jun; 30(25):2147-54. PubMed ID: 7109842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats.
    Subramanyam B; Rollema H; Woolf T; Castagnoli N
    Biochem Biophys Res Commun; 1990 Jan; 166(1):238-44. PubMed ID: 2302206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective mechanism-based inactivation of the major phenobarbital-inducible P-450 cytochrome from rabbit liver by phencyclidine and its oxidation product, the iminium compound.
    Osawa Y; Coon MJ
    Drug Metab Dispos; 1989; 17(1):7-13. PubMed ID: 2566474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The formaldehyde-donating activity of N5,N10-methylene tetrahydrofolic acid in xenobiotic biotransformation.
    Kucharczyk N; Yang JT; Wong KK; Sofia RD
    Xenobiotica; 1984 Aug; 14(8):667-76. PubMed ID: 6495760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phencyclidine in nanomolar concentrations binds to synaptosomes and blocks certain potassium channels.
    Blaustein MP; Ickowicz RK
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3855-9. PubMed ID: 6304743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in rat brain [3H]-TCP binding following chronic phencyclidine administration.
    Massey BW; Wessinger WD
    Life Sci; 1990; 47(24):PL139-43. PubMed ID: 2176262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Certain calcium antagonists are potent displacers of [3H]phencyclidine (PCP) binding in rat brain.
    Quirion R; Pert CB
    Eur J Pharmacol; 1982 Sep; 83(1-2):155-6. PubMed ID: 7128698
    [No Abstract]   [Full Text] [Related]  

  • 60. Convenient method for the analysis of nicotinic acid as a metabolite of nicotinate esters in various tissue homogenates.
    Durrer A; Walther B; Racciatti A; Testa B
    J Chromatogr; 1989 Oct; 495():256-62. PubMed ID: 2613811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.